Antonios Arvelakis, MD, MPH is a multi-organ transplant surgeon at the Recanati/Miller Transplantation Institute as well as an assistant professor of surgery at the Mount Sinai School of Medicine. Dr. Arvelakis specializes in adult liver, kidney and pancreas transplants and also has extensive experience in paired kidney donation.
Dr. Arvelakis earned his medical degree and completed his general surgery residency at the Athens University School of Medicine. He then completed his fellowship in transplant surgery at Mount Sinai Hospital and began working at the Yale New Haven Transplantation Center where he went on to become the director of the Kidney Paired Exchange program. He returned to Mount Sinai after five years of working at Yale.
In August, 2014 Dr. Arvelakis obtained a Masters Degree in Pulic Health, Health Policy and Management from Columbia University.
His research interests include Living donor liver transplantation, kidney paired donation and pancreas transplantation.
Read about Dr. Arvelakis in the Daily News article about Paired Kidney Exchange: HERE
Read about Dr. Arvelakis leading the first paired kidney swap transplant in Connecticut: HERE
MD, Athens University School of Medicine
Executive MPH, Columbia University
Residency, Surgery (General)
Athens University School of Medicine
Fellowship, Transplant Surgery
Jackson Memorial Hospital
Fellowship, Transplant Surgery
Mount Sinai Hospital
English, French, Greek
Formica RN, Barrantes F, Asch WS, Bia MJ, Coca S, Kalyesubula R, McCloskey B, Leary T, Arvelakis A, Kulkarni S. A one-day centralized work-up for kidney transplant recipient candidates: a quality improvement report. American journal of kidney diseases : the official journal of the National Kidney Foundation 2012 Aug; 60(2).
Cimsit B, Assis D, Caldwell C, Arvelakis A, Taddei T, Kulkarni S, Schilsky M, Emre S. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. Transplantation proceedings 2011 Apr; 43(3).
Cimsit B, Schilsky M, Moini M, Cartiera K, Arvelakis A, Kulkarni S, Formica R, Caldwell C, Taddei T, Asch W, Emre S. Combined liver kidney transplantation: critical analysis of a single-center experience. Transplantation proceedings 2011 Apr; 43(3).
Rosencrantz R, Cimsit B, Seashore M, Arvelakis A, Kulkarni S, Ghiroli M, Emre S. Pediatric liver transplantation for inherited metabolic liver disease: a single-center experience. Transplantation proceedings 2011 Apr; 43(3).
Emre S, Rodriguez-Davalos M, Umman V, Cartiera K, Wollwerth S, Arnott L, Arvelakis A, Schilsky M. Liver transplantation at Yale-New Haven Transplantation Center. Clinical transplants 2011;.
Caldwell C, Werdiger N, Jakab S, Schilsky M, Arvelakis A, Kulkarni S, Emre S. Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010 Jul; 16(7).
Kulkarni S, Emre S, Arvelakis A, Asch W, Bia M, Formica R, Israel G. Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy. Clinical transplantation; 25(1).
Michail P, Karavokyros I, Pikoulis E, Arvelakis A, Charminis G, Michail O, Theodoros D. Acinic cell carcinoma of the parotid gland in children: a case report and literature review. The West Indian medical journal 2008 Jan; 57(1).
Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S. Strongyloides hyperinfection syndrome after intestinal transplantation. Transplant infectious disease : an official journal of the Transplantation Society 2008 Apr; 10(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Arvelakis did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.